Home - Products - Others - Other Targets - 10-O-trans-p-methoxycinnamoyl-catalpol

10-O-trans-p-methoxycinnamoyl-catalpol

CAS No. 201605-27-8

10-O-trans-p-methoxycinnamoyl-catalpol( —— )

Catalog No. M32359 CAS No. 201605-27-8

10-O-Trans-p-methoxycinnamoylcatalpol has antioxidant activity with the IC50 value of 0.37 μM/mL in DPPH free radical scavenging assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 385 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    10-O-trans-p-methoxycinnamoyl-catalpol
  • Note
    Research use only, not for human use.
  • Brief Description
    10-O-Trans-p-methoxycinnamoylcatalpol has antioxidant activity with the IC50 value of 0.37 μM/mL in DPPH free radical scavenging assay.
  • Description
    10-O-Trans-p-methoxycinnamoylcatalpol has antioxidant activity with the IC50 value of 0.37 μM/mL in DPPH free radical scavenging assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    201605-27-8
  • Formula Weight
    522.5
  • Molecular Formula
    C25H30O12
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NGR peptide Trifluor...

    NGR peptide Trifluoroacetate containing the asparagine-glycine-arginine (NGR) motif is recognized by CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in tumor neovasculature.

  • Acetyl-(Nle4,Gln5,D-...

    Acetyl-(Nle4,Gln5,D-Phe7,D-Trp9)-α-MSH (4-10) amide

  • Bromodiphenhydramine...

    Bromodiphenhydramine hydrochloride is a new antihistaminic in the control of cutaneous.